After 28 weeks, the results showed people in each of the treatment groups lost on average: 20 pounds (lb) with a combination treatment of 15 milligrams (mg) phentermine with 92 mg topiramate 13.6 lb with 15 mg phentermine only 14.7 lb for 92 mg topiramate only This suggests that taking the drugs together rather than separately may result in greater weight loss
Infographic Brief 4 Placement: After ## FDA and Regulatory Status of GHK-Cu Peptide Title: GHK-Cu Regulatory Context Map Purpose: Clarify the difference between cosmetic products, topical or non-injectable compounding context, injectable safety concerns, investigational use, and approved prescription drugs
Preclinical data raises several interaction concerns worth noting: Anticoagulants
Here's one way of answering the question
Appetite suppression is driven by the GLP-1 receptor agonist component, and response varies based on individual GLP-1 receptor density, baseline ghrelin and leptin levels, and dietary patterns